AVLN Avalyn Pharma Inc.

NASDAQ
$27.69

Avalyn Pharma Inc. (AVLN) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus AVLN's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 1 seller in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
1
4 transactions
Purchases
$0
0 shares
Sales
$6.7M
228,454 shares
Net activity
-$6.7M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $6.7M 4 transactions · 228,454 shares

Largest single sale: $5.0M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: May 1, 2026 .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
FMR LLC 2 fills 10% Owner Sell 53,454 $30.21 $1.6M 2,103,970 −2.5% of holding
FMR LLC 2 fills 10% Owner Sell 175,000 $29.07 $5.1M 2,110,874 −7.7% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.